Efter lægemidlet er markedsført, er der meget sjældent set alvorlige allergiske reaktioner (anafylaksi), hallucinationer og ændret mental tilstand.
Since the drug has been marketed, severe allergic reactions (anaphylaxis), hallucinations, and altered mental status have been reported very rarely.